Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-03-27 @ 12:51 PM
Study NCT ID:
NCT00675857
Status:
COMPLETED
Last Update Posted:
2010-08-24
First Post:
2008-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes
Sponsor:
Bellus Health Inc. - a GSK company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CL-503011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Francis Gauthier, Project Manager
Old Organization:
Bellus Health Inc.